Intrinsiqq
China Pharma Holdings Inc. logo

China Pharma Holdings Inc. Dividend Analysis

CPHI

⊜ Compare
Dividend0
No active dividend

This company has no dividend history.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

No dividend history found in SEC filings.

Does China Pharma Holdings (CPHI) pay a dividend?

China Pharma Holdings (CPHI) has never paid a dividend. The business does generate free cash flow of $88,937.00, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does China Pharma Holdings (CPHI) pay a dividend?+

No. China Pharma Holdings (CPHI) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

How does China Pharma Holdings return cash to shareholders?+

It largely does not. China Pharma Holdings pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could China Pharma Holdings afford to pay a dividend?+

On the numbers, yes. China Pharma Holdings generated $88,937.00 of free cash flow, which is about $0.00 per share. If it paid out half of that, the dividend would be roughly $0.00 per share, a yield of about 0.2% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with China Pharma Holdings.

SourceDividend analysis computed from the 10-Q filed 11 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CPHI

CompareIntrinsic value
PRPHProPhase Labs Inc.
$0.01-42.00%0
ATAIAtaiBeckley Inc.
$0.61-1.61%40
CAMPCamp4 Therapeutics Corp.
$3.74-2.35%40
MRKRMarker Therapeutics, Inc.
$1.01+3.06%25
NRXPNRx Pharmaceuticals, Inc.
$2.49+11.16%10
CLSDQClearside Biomedical, Inc.
No recent price10
ENSCEnsysce Biosciences Inc.
$0.37-2.20%40
TXMDTherapeuticsMD, Inc.
$1.82+2.25%25

Spot a number that looks wrong? Check it in CPHI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CPHI

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.